GMED Globus Medical Inc

  1. Stocks
  2. Healthcare
  3. NYSE: GMED

Price (delayed)

$79.83

Market cap

$10.84B

P/E Ratio

18.35

Dividend/share

N/A

EPS

$4.35

Enterprise value

$10.39B

?
Relative Growth: Rel. Growth: 99
Relative Strength: Rel. Strength: 52
Relative Valuation: Rel. Valuation: 81
Relative Profitability: Rel. Profitability: 94

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing ...

Highlights
The P/E is 69% less than the 5-year quarterly average of 58.1 and 12% less than the last 4 quarters average of 20.6
The gross profit has grown by 38% YoY and by 6% from the previous quarter
The debt has increased by 25% year-on-year but it has declined by 2.9% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.globusmedical.com
Peers: SYK OFIX ATEC

Key stats

What are the main financial stats of GMED

GMED stock price

How has the Globus Medical stock price performed over time
Intraday
0.81%
1 week
2.98%
1 month
-5.87%
1 year
38.09%
YTD
-8.57%
QTD
-7.35%

Financial performance

How have Globus Medical's revenue and profit performed over time
Revenue
$3.1B
Gross profit
$2.1B
Operating income
$533.2M
Net income
$586.71M
Gross margin
67.9%
Net margin
18.9%
The net margin has surged by 155% year-on-year and by 3.3% since the previous quarter
The operating income has soared by 109% YoY and by 11% QoQ
The company's operating margin has surged by 69% YoY and by 6% QoQ
The gross profit has grown by 38% YoY and by 6% from the previous quarter

Price vs fundamentals

How does GMED's price correlate with its fundamentals

Growth

What is Globus Medical's growth rate over time

Valuation

What is Globus Medical stock price valuation
GMED P/E details
P/E
18.35
P/B
2.28
P/S
3.49
EV/EBIT
16.05
EV/EBITDA
11.19
EV/Sales
3.35
The P/E is 69% less than the 5-year quarterly average of 58.1 and 12% less than the last 4 quarters average of 20.6
The EPS has grown by 9% since the previous quarter
The stock's P/B is 22% less than its 5-year quarterly average of 2.9 but 2.7% more than its last 4 quarters average of 2.2
GMED's equity is up by 16% year-on-year and by 3.5% since the previous quarter
GMED's P/S is 33% lower than its 5-year quarterly average of 5.2
Globus Medical's revenue has increased by 23% YoY and by 6% QoQ

Efficiency

How efficient is Globus Medical business performance
Globus Medical's return on equity has surged by 183% YoY and by 4.8% QoQ
GMED's ROIC has soared by 136% year-on-year
The return on sales has surged by 125% year-on-year and by 3% since the previous quarter
The ROA is up by 6% since the previous quarter

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical financials performed over time
GMED's total assets is up by 15% year-on-year and by 2.6% since the previous quarter
The company's total liabilities rose by 14% YoY but it fell by 3.1% QoQ
The debt is 98% smaller than the equity
The company's debt to equity fell by 33% QoQ
The debt has increased by 25% year-on-year but it has declined by 2.9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.